Limula is building a smart automation solution for the production of the most complex, most expensive, but also most personalized cancer treatment ever invented.
Limula has raised €6.5M across 4 funding rounds from 9 investors. Based in Vaud, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| — | Other | — | — | View deal → |
| 2024-05-21 | Seed | €6.3M | Angel Investors,Lichtsteiner Foundation,LifeX Ventures,Oxford Seed Fund,Verve Ventures,W.A. de Vigier Foundation+1 more | View deal → |
| 2023-10-16 | Other | €237k | BioTools Innovator | View deal → |
| 2022-10-11 | Other | — | Biopôle Start-up Fund | View deal → |
